Simplex Trading’s Profound Medical PROF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$48.6K Buy
7,500
+7,400
+7,400% +$51.1K ﹤0.01% 5912
2025
Q4
$787 Buy
+100
New +$643 ﹤0.01% 8079
2025
Q3
Sell
-500
Closed -$2K 9839
2025
Q2
$2K Hold
500
﹤0.01% 8189
2025
Q1
$2K Buy
+500
New +$3.45K ﹤0.01% 8048
2024
Q3
Sell
-200
Closed -$1K 9335
2024
Q2
$1K Hold
200
﹤0.01% 8530
2024
Q1
$1K Buy
+200
New +$1.67K ﹤0.01% 8624
2023
Q1
Sell
-8,500
Closed -$92K 9890
2022
Q4
$92K Sell
8,500
-6,400
-43% -$34.9K ﹤0.01% 5186
2022
Q3
$60K Hold
14,900
﹤0.01% 6191
2022
Q2
$108K Buy
14,900
+800
+6% +$6.33K ﹤0.01% 5477
2022
Q1
$126K Buy
14,100
+3,500
+33% +$33.7K ﹤0.01% 5825
2021
Q4
$119K Sell
10,600
-5,200
-33% -$64.9K ﹤0.01% 5974
2021
Q3
$260K Hold
15,800
﹤0.01% 5150
2021
Q2
$258K Buy
15,800
+15,749
+30,880% +$293K ﹤0.01% 5240
2021
Q1
$102K Buy
51
+50
+5,000% +$1.2K ﹤0.01% 5722
2020
Q4
$2K Buy
+1
New +$18 ﹤0.01% 7998

Other funds holding PROF

Simplex Trading's PROF Position: Q1 2026 in Review

Simplex Trading increased its Profound Medical (PROF) stake by 6,050% in Q1 2026, buying an estimated $250K and bringing the position to 36,718 shares worth $238K. The position accounts for ﹤0.01% of the portfolio, ranked #4087.

Simplex Trading first reported a position in PROF in Q1 2021 and has held it in 12 quarters since. 57 funds tracked by Wall St. Rank hold PROF as of Q1 2026.

  • Simplex Trading held 36,718 shares of Profound Medical worth $238K as of Q1 2026.
  • Simplex Trading bought 36,121 Profound Medical shares in Q1 2026, an estimated $250K.
  • Profound Medical made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #4087 holding.
  • Simplex Trading first reported a position in Profound Medical in Q1 2021 and has held it in 12 quarters since.
  • 57 funds tracked by Wall St. Rank held Profound Medical as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.